GB2349877A - Preparing carbonated hydroxyapatite - Google Patents
Preparing carbonated hydroxyapatite Download PDFInfo
- Publication number
- GB2349877A GB2349877A GB9910847A GB9910847A GB2349877A GB 2349877 A GB2349877 A GB 2349877A GB 9910847 A GB9910847 A GB 9910847A GB 9910847 A GB9910847 A GB 9910847A GB 2349877 A GB2349877 A GB 2349877A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydroxyapatite
- carbonate
- heating
- atmosphere
- molar ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title claims abstract description 96
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims abstract description 92
- 238000000034 method Methods 0.000 claims abstract description 49
- 238000010438 heat treatment Methods 0.000 claims abstract description 29
- 238000002360 preparation method Methods 0.000 claims abstract description 15
- -1 ammonium ions Chemical class 0.000 claims abstract description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 5
- 239000011734 sodium Substances 0.000 claims abstract description 5
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 5
- 125000005587 carbonate group Chemical group 0.000 claims description 15
- 238000001556 precipitation Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 abstract description 21
- 239000011575 calcium Substances 0.000 description 65
- 229910002092 carbon dioxide Inorganic materials 0.000 description 29
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 28
- 238000006467 substitution reaction Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 13
- 239000000463 material Substances 0.000 description 11
- 238000005245 sintering Methods 0.000 description 10
- 238000002441 X-ray diffraction Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 229910052586 apatite Inorganic materials 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 239000000919 ceramic Substances 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- 239000000292 calcium oxide Substances 0.000 description 5
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 238000000160 carbon, hydrogen and nitrogen elemental analysis Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000316 bone substitute Substances 0.000 description 3
- 235000010216 calcium carbonate Nutrition 0.000 description 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 3
- 239000000920 calcium hydroxide Substances 0.000 description 3
- 235000011116 calcium hydroxide Nutrition 0.000 description 3
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 239000011343 solid material Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 238000001354 calcination Methods 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 229910010293 ceramic material Inorganic materials 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 229940077441 fluorapatite Drugs 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/32—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Materials For Medical Uses (AREA)
Abstract
A process for the preparation of a carbonate-substituted hydroxyapatite comprising heating an hydroxyapatite having a Ca/P molar ratio greater than 1.67 but less than approximately 1.82 at 600 to 1200{C in a atmosphere comprising CO<SB>2</SB>, and optionally H<SB>2</SB>O. This process enables a substantially single phase carbonate-substituted hydroxyapatite composition to be produced which does not contain sodium or ammonium ions.
Description
1 2349877 METHOD FOR THE PREPARATION OF CARB(MATED HYDROXYAPATITE
COMPOSITIONS The present invention relates to a method for forming carbonated hydroxyapatite compositions and, in particular, to a method for forming carbonated hydroxyapatite compositions which are substantially sodium-free and ammonium-free and which are substantially of a single phase.
Synthetic hydroxyapatite Cajo (P04) 6 (OH) 2 has been reported as having been used as a bone replacement material in porous, granular, plasma sprayed and dense forms. Investigations have shown hydroxyapatite to be similar structurally to bone.material. However hydroxyapatite is one of the range of stoichiometric calcium phosphate apatites. Human and animal bone mineral have been shown to contain significant amounts of from 3 to 7 wt% of carbonate. There is evidence that the carbonate group can substitute in two sites, the phosphate and hydroxyl sites, termed B and A respectively; bone mineral being predominately a B type apatite. As a result of this similarity in chemical composition, it is envisaged that carbonated hydroxyapatite will have better bioactivity than unsubstituted stoichiometric hydroxyapatite which is currently used in commercial applications, such as plasma-sprayed coatings on metallic implants and porous hydroxyapatite ceramic bone substitutes. A carbonate substituted hydroxyapatite would also find application for use in chromatography and for purification, such as the removal of heavy metal ions by adsorption.
The preparation of carbonate-substituted hydroxyapatite ceramic materials must be easy and reproducible in order to achieve commercial exploitation. Additionally, the carbonate-substituted hydroxyapatite composition must be thermally stable such that it will not decompose to undesirable secondary phases (e.g. tricalcium. phosphate or calcium oxide) upon calcining/sintering. Furthermore, during this heat treatment, the carbonate-substituted hydroxyapatite must not lose the carbonate ions that have been substituted into the hydroxyapatite structure.
Up to the present time, the methods which have been reported to prepare carbonate-substituted hydroxyapatite compositions have involved one of the following procedures.
The heating of a stoichiometric hydroxyapatite ceramic composition in a C02 atmosphere at approximately 9000C for several days (R.Wallaeys, Silicon, Sulphur, Phosphates. Coll. Int. Union Pure Appl. Chem. MUnster (1954) 183-1901. This process results in low levels of carbonate substitution, with poor control over the extent of carbonate substitution and the homogeneity of the substitution throughout the sample. Furthermore, the carbonate substitution is at the wrong site, i.e. the A site, to provide a material which is equivalent to bone.
A wet precipitation method using Na2CO3, NaHC03 or (NH4)2CO3 as a source of carbonate ions [See, for example: Y. Doi, Y. Moriwaki, T. Aoba, M. Okazati, J.
Takahashi and K. Joshin, "Carbonate apatites from aqueous and non-aqueous media studied by esr, IR and X-Ray Diffraction: Effect of NH4+ ions on crystallographic parameters", J. Deut. Res. 61(1982) 429-434, D.G.A. Nelson and J.D.B. Featherstone, "Preparation analysis and characterization of Carbonated apatites", Calcif. Tiss. Int. 34(1082) 569 581]. This process results in the substitution of the additional ions, Na+ or NH4+, into the hydroxyapatite structure, poor thermal stability of the product upon calcining/sintering, the loss of large quantities of the carbonate ions upon heating, and poor control of the levels of the carbonate substitution.
Incorporation of carbonate ions by soaking carbonate-free samples in a saturated solution of carbon-dioxide. [E.G. Nordstr6m and K.H. Karlsson, "Carbonate-doped hydroxyapatite", J.Mat. Sci. Mater. Med. 1 (1990) 1821841. A soaking time of 2 months gives a carbonate content of 4 to 5.5 wt% as determined by TGA. At 11000C a 3.3wt% C02 loss was registered. This method involves soaking pure, stoichiometric, sintered hydroxyapatite ceramic powder in mineral water for up to 2 months to try to lionexchange' carbonate ions from solution into the hydroxyapatite ceramic.
Sintering of stoichiometric hydroxyapatite in a C02atmosphere for several days to give A-type substitution. Co- precipitating some carbonate and some calcium phosphate to give B-type substitution. Reacting fluorapatite and alkaline earth carbonate at 900C in dry carbon dioxide gas to give B-type substitution [all described in G. Bonel, "Contribution a 1'6tude de la carbonation des apatites", Ann. Chim. 7 (1972) 127-1441.
Slowly adding a solution of calcium nitrate in contact with carbon dioxide gas to a solution of ammonium phosphate (pH=8.6,80'C). The precipitation lasts 64 hours and the suspension is maintained at the above conditions for a further 51 hours [A. Barroug, C. Rey, J.C. Trombe and G. Montel, "The synthesis in aqueous-media of AB carbonate apatite similar to dental enamel", C.R.Acad. Sc. Paris 292[3] (1981) 303 3061. After ageing for 51 hours the apatite contains 1.3 wt% carbonate. Chemical analysis gives a Ca/P ratio of 1.63-1.61. No heat treatment is carried out so the stability of the apatite and the carbonate content after heating/sintering is unknown.
Neutralization of a Ca(M2 solution with H3P04 under stirring at 37'C in presence Of C02 [A. Bigi, F.
Marchetti, A. RiPamonti, N. Roveri and E. Foresti, "Magnesium and strontium interaction with carbonate containing hydroxyapatite in aqueous medium", J.
Inorg. Biochem. 15 (1981) 317-3271. The product is stored for one week in contact with the mother solution, then filtered, washed with distilled water, and dried at 1000C. Hydroxyapatite with a Ca/P molar ratio of 1.95 is obtained. The carbonate content (FTIRI is 6 wt% in a sample dried at 1000C, decreasing to a value of 2.5 wt% in a sample heat treated at 7000C, and is undetectable at 10000C.
EP-A-0722773 and JP-A-8225312 disclose the preparation of an A-type substituted hydroxyapatite in which the carbonate ions substitute for OHions in the structure.
EP-A-0626590 discloses the preparation of a carbonate substituted apatite in which the Ca/P ratio is maintained at approximately 1.66 and sodium and carbonate ions are co-substituted into the lattice with the amount of carbonate that is substituted being controlled by the amount of sodium bicarbonate used in the reaction.
WO-A-94/08458 discloses a process for the preparation of carbonated hydroxyapatite in which the starting materials are mixed at room temperature and the material sets to form a cement at room or physiological temperature. The source of carbonate ions is solid calcium carbonate. The material produced is poorly-crystalline or amorphous apatite which contains sodium ions.
JP-A-61151011 discloses adding Ca(OH)2 and CaCO3 to a slurry of CaHP04. The C03 ions are introduced into the reaction mixture as insoluble CaC03 and not via solution. The ratios of Ca/P used are always less than 1.67. After sintering at 1000' to 11000C the carbonate content of the resulting material is less than 0.1%.
It is mainly due to the problems encountered with the preparation routes discussed above that these routes have not been developed to prepare carbonate substituted hydroxyapatite ceramic materials commercially.
We have now developed a novel process for the preparation of a substantially single phase carbonate substituted hydroxyapatite composition which overcomes the problems of the prior art methods and does not contain sodium or ammonium ions.
Accordingly, the present invention provides a process for the preparation of a carbonate-substituted hydroxyapatite, which process comprises heating an hydroxyapatite having a Ca/P molar ratio greater than 1.67 but less than approximately 1.82 at a temperature of from 600 to 12000C in an atmosphere comprising C02.
Preferably the atmosphere also comprises H20.
The presence of H20 appears to increase the maximum temperature that can be used without decomposition of the product.
Carbonate-substituted hydroxyapatites, containing between 0 and 5 Wt% C03 2-, may be prepared by this simple process. Furthermore, the carbonate substituted hydroxyapatites produced by this process are substantially single phase. This means that greater than 98%, preferably greater than 99% and most preferably approximately 100% of the structure is of a single phase. Also, the carbonate-substituted hydroxyapatites produced by this process are substantially free of sodium and ammonium ions.
Carbonate-substituted hydroxyapatites prepared by this process have both A-type and B-type substitution.
When the heat-treatment takes place at a lower temperature, such as 600-7000C, there is a roughly equal mix of A-type and B-type substitution and the products may be represented by the general formula Calo (P04) 6-x (C03) x (OH) 2-x (C03) x where x is greater than 0 and less than or equal to 0.5.
Commonly however some A-type substituted carbonate is lost on heat treatment at higher temperatures, such as 900- 1000'C or above, and this is most noticeable as the level of carbonate substitution is increased. Higher temperatures such as 900-1000'C are required to sinter the carbonate-substituted hydroxyapatite to near-theoretical densities, for applications such as granules and dense and porous ceramics. The loss of carbonate can be represented by the equation below:
Calc) (P04) 6-x (C03) X (OH) 2-x (C03) x 1 Calo (P04) 6-x (C03) x (OH) 2-X (C03) x-yOy + YC02 Where y increases as the temperature increases. There is a point, when y increases significantly, where CaO will form. Thus, at higher temperatures, carbonatesubstituted hydroxyapatites will (a) eventually decompose to a purely B-type carbonate-substituted hydroxyapatite and calcium oxide and (b) be limited in the amount of carbonate substitution that can be made.
In the context of the present specification hydroxyapatites having a Ca/P molar ratio greater than 1.67 but less than approximately 1.82 will be referred to as "Ca-rich" hydroxyapatites.
A Ca-rich hydroxyapatite is preferably prepared by process which comprises as an essential step a precipitation reaction between Ca(OW2 and H3P()4.
A suitable process for preparing a Ca-rich hydroxyapatite, which comprises as an essential step a precipitation reaction between Ca(OH)2 and H3PC)4, may comprise the steps of:
(i) providing a suspension of Ca(OH)2 in water and a solution of H3P04 in water, (ii) adding the solution to the suspension, preferably in a dropwise manner, to provide a mixture wherein the molar ratio of Ca/P is greater than 1.67 but less than approximately 1.82, (iii) optionally adjusting the pH of the mixture resulting from step (ii) to a value in the range of from 10 to 11, preferably by the addition of ammonia, (iv) optionally stirring the mixture resulting from step (ii) or step (iii), preferably for a period of from 1 to 3 hours, (v) allowing the mixture obtained from any one of steps (ii), (iii) or (iv) to age without stirring, preferably for a period of from 5 to 24 hours, (vi) isolating solid material from the mixture resulting from step (v), preferably by filtration, (vii) drying the solid material isolated in step (vi), preferably by heating at approximately 800C for a period of from 5 to 24 hours, (viii) optionally forming the dry solid material resulting from step (vii) into a powder, said powder preferably consisting of particles substantially all of which have a particle size of less than approximately 10Ogm.
For the Ca-rich mixtures resulting from step (ii), i.e. Ca/P > 1.67, the pH will generally be greater than 9, and for Ca/P > 1.70 the pH will be greater than 10, thus ideally no ammonia needs to be added.
By preparing the hydroxyapatite with a Ca/P molar ratio > 1.67 but less than approximately 1.82, vacancies' or IspacesF are left in the phosphate sites of the hydroxyapatite structure. The extent of incorporation Of C03 2- into the structure depends upon the number of available 'vacancies' and can therefore be controlled by controlling the Ca/P molar ratio, i.e. the higher the Ca/P molar ratio, the more carbonate ions can be substituted into the structure.
Preferably the hydroxyapatite is prepared with a Ca/P molar ratio in the range of from 1.69 to 1.82, more preferably from 1.72 to 1.78. Most preferably the Ca/P molar ratio is approximately 1.76.
The calcium-rich hydroxyapatites are heattreated/sintered at a temperature of from 600 to 12000C, depending upon the desired carbonate content and the desired density properties of the product. As mentioned above, lower temperatures result in higher levels of carbonate substitution since carbonate is lost as C02 at higher temperatures. However, at higher temperatures a higher density sintered product is obtained. Thus, the choice of temperature results from a balance between the desired carbonate content and the desired density properties of the product.
Preferably the heating occurs at a temperature of from 850 to 10OCC. More preferably the heating occurs at a temperature of from 900 to 9500C.
Preferably a tube furnace is used for the heating process. The tube furnace is sealed at both ends with one or more gas inlets and one or more gas outlets attached at either end. The rate of heating to the desired temperature may be from 1 to 20'/min, preferably from 2.5 to 5'/min and most preferably approximately 2.50/min.
Above these temperatures, partial decomposition to hydroxyapatite + CaO/CaCO3 is observed. This therefore results in a product which is not substantially single phase. The C02 from the sintering atmosphere is incorporated into the hydroxyapatite structure as C03 2- groups which occupy, predominantly, the phosphate sites.
The concentration of C02 in the atmosphere may be controlled by altering the flow-rate Of C02 gas through the heating apparatus. Preferably the flowrate is in the range of from 0.5 to 3 llmin, more preferably from 1 to 2 1/min and most preferably approximately 1.5 1/min.
The concentration of H20 in the atmosphere, if included, will depend upon the concentration of C02 and the heating temperature. A suitable concentration of H20 in the atmosphere may be achieved by passing the C02 gas through a container of water, preferably at room temperature, prior to its entry into the heating apparatus.
The heating may be carried out for a period of from 1 to 24 hours. Preferably, the heating is carried out for a period of from 1 to 8 hours. More preferably, the heating is carried out for a period of from 1 to 4 hours. Most preferably the heating is carried out for a period of from 1 to 2 hours.
By the method of the present process, a dense, crystalline, single-phase carbonate-substituted hydroxyapatite is obtained. The process allows a controlled amount of carbonate ions to be substituted into hydroxyapatite, with the amount being determined by the level of Ca/P molar ratio i.e. the higher the Ca/P molar ratio, the more carbonate ions can be substituted into the structure. A carbonatesubstituted hydroxyapatite can be prepared by this method which has a carbonate content comparable to bone, with the carbonate substitution being predominantly on the B-site (the phosphate site) of hydroxyapatite. This process is extremely simple and it reduces the possibility of producing a material that will not be single-phase.
The carbonated hydroxyapatite compositions prepared in accordance with the present invention may be used in any of the applications for which hydroxyapatite is used, for example; the formation of plasma-sprayed coatings on metallic implants, the formation of porous ceramic bone substitutes, the preparation of composites with polymeric materials such as high density polyethylene, as granules or beads for packing or filling bone defects, as materials for use in chromatography or as materials for use in purification methods such as the removal of heavy metals by adsorption.
The present invention will be further described with reference to the accompanying drawings in which:
Figure 1 shows an X-ray diffraction pattern for a Ca-rich hydroxyapatite (HA) having Ca/P = 1.76 which has been heat-treated at 900'C in C02/H20. For comparison there is also shown an X-ray diffraction pattern for stoichiometric hydroxyapatite (HA) having Ca/P = 1.67 which has also been heat-treated at 9000C in C02/H20. The standard peaks of HA are marked on the diagram by black dots (from the ICDD (JCPDS) standard for HA, PDF No. 9- 432).
Figure 2 shows an X-ray diffraction pattern for a Ca-rich hydroxyapatite (HA) having Ca/P = 1.76 as precipitated. For comparison there is also shown an X-ray diffraction pattern for stoichiometric hydroxyapatite (HA) having Ca/P = 1.67 as precipitated.
The present invention will be further described by reference to the following examples (and comparative examples) which are intended to illustrate the present invention but not to limit its scope.
Exgm ples Initial vrenaration of stoichiometric and Ca-rich hydroxyapatijes.
A 'calcium' suspension (suspension A) was prepared by dispersing the appropriate quantity, see Table 1, of Ca (OH) 2 (BDH AnalaR) in 1 litre of deionised water. Suspension A was stirred for 15 minutes prior to the precipitation reaction. Phosphoric acid, H3P041 (BDH GPR 85% assay 0.3 moles 34.588g) was added to 1 litre of deionised water (solution B). Solution B was stirred for 15 minutes prior to the precipitation reaction.
Solution B was added dropwise to suspension A, which was stirred constantly; the addition of solution B took approximately 3 hours and was performed at room temperature. After the solution B was added, the pH of the resulting mixture (mixture C) was adjusted to 10.5-11 with ammonia (BDH AnalaR). Mixture C was then stirred for 2 hours and aged overnight without stirring. The aged mixture C was filtered and the resulting filtercake was dried at 800C overnight. The dried filtercake was crushed and ground to a fine powder.
Sample ED Name Ca (moles) CaffiH)2(g) Ca/P CaAP=1.67 Stoichiometric hydroxyapatite 0.500 37.049 1.67 Ca/l---1.72 Ca-rich hydroxyapatite 0.516 38.250 1.72 Ca/P=1.76 Ca-fich hydroxyapatite 0.528 39.124 1.76 CaAP=1.78 Ca-fich hydroxyapatite 0.534 39.568 1.78 Table 1. Quantities of Ca (OH) 2 used to prepare Ca-rich hydroxyapatites (Ca/P = 1.72, 1.76 and 1.78) and stoichiometric hydroxyapatite (Ca/P=1. 67). 25 Comparative Example 1: Preparation of carbonatesubstituted hydroxyapatite from stoichiometric hydroxyapatite.
A stoichiometric hydroxyapatite (Ca/P = 1.67) was prepared by the above method. The stoichiometric hydroxyapatite was heat-treated in a tube furnace at 90CC for 2 hours in a C02/H20 atmosphere. The C02/H20 atmosphere was provided by a flow-rate of 1.5 1/min of C02 through the furnace, the C02 being bubbled through water at room temperature prior to entering the furnace. The as- precipitated and the calcined/sintered powders of the stoichiometric hydroxyapatite (Ca/P = 1.67) have been characterised by CHN analysis, XRF, XRD and FTIR.
Comparative Ex@.mple 2.: Preparation of carbonatesubstituted hvdroxvaiDatite from stoichiometric hvdroxvaDatite.
A stoichiometric hydroxyapatite (Ca/P = 1.67) was prepared by the above method. The stoichiometric hydroxyapatite was heat- treated in a tube furnace at 9000C for 2 hours in air. The as- precipitated and the calcined/sintered powders of the stoichiometric hydroxyapatite (Ca/P = 1.67) have been characterised by CHN analysis and XRF.
Example 1: PreiDaration of carbonate-substituted hvdroxvaDatite from Carich hvdroxvaDatite.
A Ca-rich hydroxyapatite (Ca/P = 1.76) was prepared by the above method. The Ca-rich hydroxyapatite was heat-treated in a tube furnace at 90CC for 2 hours in a C02/H20 atmosphere. The C02/H20 atmosphere was provided by a flow-rate of 1.5 1/min of C02 through the furnace, the C02 being bubbled through water at room temperature prior to entering the furnace. The asprecipitated and the calcined/sintered powders of the Ca-rich hydroxyapatite (Ca/P = 1.76) have been characterised by CHN analysise XRF, XRD and FTIR. Results from analysis indicate that the carbonate-substitution is a combined ABtype substitution, described by the formula:
Cajo (P04) 6-x (C03), (OH) 2-x (C03) x-y Oy Substitution is predominantly B-type due to the higher sintering temperature of 9000C that was used, and the associated loss of some C02 from the A-sites.
CoMparative ExamiDle 3-: Preparation of carbonatesu)2stituted hydroxyapatite from Ca-rich hvdroxvanatite.
A Ca-rich hydroxyapatite (Ca/P = 1.76) was prepared by the above method. The Ca-rich hydroxyapatite was heat-treated in a tube furnace at 90CC for 2 hours in air. The as-precipitated and the calcined/sintered powders of the Ca-rich hydroxyapatite (Ca/P = 1.76) have been characterised by CHN analysis and XRF.
CHN and XRF data are summarised in Table 2.
Within the experimental errors of the XRF method, the calculated and measured values are comparable (experimental errors are shown in brackets). The CHN analysis of both the stoichiometric hydroxyapatite and the Ca-rich hydroxyapatite show that both materials in the as-precipitated stage have appreciable levels of C03. These levels will result from the absorption/adsorption Of C03 2- during precipitation, both from solution and from the atmosphere, especially as the precipitate is at a high pH. For stoichiometric hydroxyapatite, this C03'_ 'S lost during heattreatment/ sintering in C02/H20 and in air.
The C03 2- content of the Ca-rich hydroxyapatite increases upon sintering in C02/H20 to a value of 3.2 wt% but decreases on sintering in air.
Sample id Method Ca/P Ca/P 0 2- 2_ (calculated) (XWF) Wt /OC03 Wto/O C03 (as-pptd) (heat-treated) Ca/P=1.67 C02/H20 1.67 1.68(1) 1.7 < 0.1 Stoichiometric Hydroxyapatite Air 1.67 1.68(1) 1.7 0 Ca/P=1.76 C02/H20 1.76 1.75(1) 2.4 3.2 Ca-rich Hydroxyapatite Air 1.76 1.75(1) 2.4 0.5 Table 2: Results of CHN and XRF analysis of carbonatesubstituted hydroxyapatite.
Figures 1 and 2 show X-ray Diffraction data (25-40' 20) for calcined/ sintered (900(5C C02/H20) and as-precipitated Ca-rich hydroxyapatite(HA), respectively; stoichiometric hydroxyapatite is included for reference. No additional phases were observed in any of the diffraction patterns.
Referring to Figure 1, the X-ray diffraction patterns of calcined/sintered samples with Ca/P=1.67 and 1.76 show only peaks corresponding to hydroxyapatite(JCPDS Card no. 9-432, shown by black dots).
The X-ray diffraction pattern of Ca-rich hydroxyapatite sintered in air at 900'C for 2 hours (not shown) gave peaks corresponding to hydroxyapatite and CaO indicating that the as-precipitated material had decomposed due to the large loss of carbonate.
Claims (16)
- Claims A process for the preparation of a carbonatesubstitutedhydroxyapatite, which process 5 comprises heating an hydroxyapatite having a Ca/P molar ratio greater than 1.67 but less than approximately 1. 82 at a temperature of from 600 to 12000C in a atmosphere comprising C02.
- 2. A process as claimed in claim 1 wherein the atmosphere additionally comprises H20.
- 3. A process as claimed in claim 1 or claim 2 wherein the hydroxyapatite having a Ca/P molar ratio greater than 1.67 but less than approximately 1.82 is synthesised by a process which comprises a precipitation reaction between Ca (OH) 2 and H3P04
- 4. A process as claimed in any one of the preceding claims wherein the Ca/P molar ratio is in the range of from 1.69 to 1.82.
- 5. A process as claimed in any one of the preceding claims wherein the Ca/P molar ratio is in the range of from 1.72 to 1.78.
- 6. A process as claimed in any one of the preceding claims wherein the Ca/P molar ratio is approximately 1.76.
- 7. A process as claimed in any one of the preceding claims wherein the heating occurs at a temperature of from 850 to 10000C.
- 8. A process as claimed in any one of the preceding claims wherein the heating occurs at a temperature of from 900 to 95CC.
- 9. A process as claimed in any one of the preceding claims wherein the concentration Of C02 in the atmosphere is controlled by providing a flow-rate Of C02 gas through the heating apparatus in the range of from 0.5 to 3 1/min.
- 10. A process as claimed in any one of claims 2 to 9 wherein H20 is introduced into the atmosphere by passing the atmosphere comprising C02 through a container of water prior to its entry into the heating apparatus.
- 11. A process as claimed in any one of the preceding claims wherein the heating is carried out for a period of from 1 to 24 hours.
- 12. A process as claimed in any one of the preceding claims wherein the heating is carried out for a period of from 1 to 2 hours.
- 13. A substantially single phase carbonate- substituted hydroxyapatite whenever produced by a process as claimed in any one of claims 1 to 12.
- 14. A substantially single phase carbonate substituted hydroxyapatite according to claim 13 2containing between 0 and 5 wt% C03
- 15. A substantially single phase carbonatesubstituted hydroxyapatite according to claim 13 35 or claim 14 which is substantially free of sodium and ammonium ions.
- 16. A process substantially as hereinbefore described with reference to the example.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9910847A GB2349877A (en) | 1999-05-10 | 1999-05-10 | Preparing carbonated hydroxyapatite |
| PCT/GB2000/001738 WO2000068144A1 (en) | 1999-05-10 | 2000-05-05 | Method for the preparation of carbonated hydroxyapatite compositions |
| AU45921/00A AU4592100A (en) | 1999-05-10 | 2000-05-05 | Method for the preparation of carbonated hydroxyapatite compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9910847A GB2349877A (en) | 1999-05-10 | 1999-05-10 | Preparing carbonated hydroxyapatite |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9910847D0 GB9910847D0 (en) | 1999-07-07 |
| GB2349877A true GB2349877A (en) | 2000-11-15 |
Family
ID=10853188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9910847A Withdrawn GB2349877A (en) | 1999-05-10 | 1999-05-10 | Preparing carbonated hydroxyapatite |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU4592100A (en) |
| GB (1) | GB2349877A (en) |
| WO (1) | WO2000068144A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2338531A1 (en) * | 2009-12-28 | 2011-06-29 | AKADEMIA GORNICZO-HUTNICZA im. Stanislawa Staszica | Method for fabrication of synthetic bioceramic implant material based on carbonate hydroxyapatites |
| EP2632504B1 (en) | 2010-10-26 | 2019-09-04 | Cap Biomaterials, LLC | Composites of hydroxyapatite and calcium carbonate and related methods of preparation and use |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015086097A (en) * | 2013-10-30 | 2015-05-07 | 三菱製紙株式会社 | (carbonate) calcium apatite containing strontium and method of producing fine particle of the same |
| PL442461A1 (en) * | 2022-10-06 | 2024-04-08 | Sieć Badawcza Łukasiewicz - Instytut Ceramiki I Materiałów Budowlanych | Synthetic bioactive hydroxyapatite material and method of its preparation |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994008458A1 (en) * | 1992-10-16 | 1994-04-28 | Norian Corporation | Carbonated hydroxyapatite compositions and uses |
| EP0625490A1 (en) * | 1993-05-19 | 1994-11-23 | Queen Mary And Westfield College | Method for the preparation of carbonated hydroxyapatite compositions |
| EP0722772A1 (en) * | 1995-01-18 | 1996-07-24 | Mitsubishi Materials Corporation | Column packing material comprising OH-carbonated hydroxyapatite |
| JPH08225312A (en) * | 1995-01-18 | 1996-09-03 | Agency Of Ind Science & Technol | Method for producing OH-based carbonated hydroxyapatite |
-
1999
- 1999-05-10 GB GB9910847A patent/GB2349877A/en not_active Withdrawn
-
2000
- 2000-05-05 WO PCT/GB2000/001738 patent/WO2000068144A1/en not_active Ceased
- 2000-05-05 AU AU45921/00A patent/AU4592100A/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994008458A1 (en) * | 1992-10-16 | 1994-04-28 | Norian Corporation | Carbonated hydroxyapatite compositions and uses |
| EP0625490A1 (en) * | 1993-05-19 | 1994-11-23 | Queen Mary And Westfield College | Method for the preparation of carbonated hydroxyapatite compositions |
| EP0722772A1 (en) * | 1995-01-18 | 1996-07-24 | Mitsubishi Materials Corporation | Column packing material comprising OH-carbonated hydroxyapatite |
| JPH08225312A (en) * | 1995-01-18 | 1996-09-03 | Agency Of Ind Science & Technol | Method for producing OH-based carbonated hydroxyapatite |
Non-Patent Citations (1)
| Title |
|---|
| WPI abstract 96-450840 & JP 08 225 312 A * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2338531A1 (en) * | 2009-12-28 | 2011-06-29 | AKADEMIA GORNICZO-HUTNICZA im. Stanislawa Staszica | Method for fabrication of synthetic bioceramic implant material based on carbonate hydroxyapatites |
| EP2632504B1 (en) | 2010-10-26 | 2019-09-04 | Cap Biomaterials, LLC | Composites of hydroxyapatite and calcium carbonate and related methods of preparation and use |
| EP2632504B2 (en) † | 2010-10-26 | 2025-04-02 | Cap Biomaterials, LLC | Composites of hydroxyapatite and calcium carbonate and related methods of preparation and use |
Also Published As
| Publication number | Publication date |
|---|---|
| AU4592100A (en) | 2000-11-21 |
| GB9910847D0 (en) | 1999-07-07 |
| WO2000068144A1 (en) | 2000-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4540225B2 (en) | Process for producing magnesium and carbonate substituted hydroxyapatite | |
| JP2010100521A (en) | Single-phase carbonate-substituted hydroxyapatite composition | |
| US9265859B2 (en) | Biomedical materials | |
| Chaair et al. | Synthesis of β-tricalcium phosphate | |
| KR20140020605A (en) | Whitlockite and method for manufacturing the same | |
| Kannan et al. | Synthesis and thermal stability of sodium, magnesium co-substituted hydroxyapatites | |
| JPH0369844B2 (en) | ||
| AU2006263624B2 (en) | Biomedical materials | |
| GB2349877A (en) | Preparing carbonated hydroxyapatite | |
| JPS5951485B2 (en) | Production method of CaO-P↓2O↓5-based apatite | |
| JP3668530B2 (en) | Method for producing tetracalcium phosphate | |
| Salahi et al. | Synthesis and thermal behaviour of β tricalcium phosphate precipitated from aqueous solutions | |
| Song et al. | In situ synthesis of silicon-substituted biphasic calcium phosphate and their performance in vitro | |
| JPS63159207A (en) | Production of hydroxyapatite | |
| JPH06122510A (en) | Method for producing hexacalcium phosphate | |
| KR960012708B1 (en) | Process for the preparation of hydroxy appatite | |
| Elliott | Formation of Fluoridated Hydroxyapatite by Competitive Attack of OH-and F-ions onto. ALPHA.-or. BETA.-Tricalcium Bis (Orthophosphate) | |
| CHAAIR et al. | SYNTHESIS Of b TRICALCIUM PHOSPHATE SYNTHÉSE DU PHOSPHATE TRICALCIQUE b | |
| IR et al. | 4NS, UK; 2 National Institute of Biomedical Engineering, Praca do Coronel Pacheco, No. 1, 4050 | |
| Matsugasaki | Osaka Sangyo University, Nakagaito, Daito, Osaka 574-0013, Japan; 2 ISIR, Osaka University, Mihogaoka, Ibaraki, Osaka 567-0047, Japan; 3 Kyoto Institute of Technology, Goshokaidocho | |
| BONE-LIKE | b Department of Chemistry, Materials and Forensic Science, University of | |
| JP2020007190A (en) | Method for producing hydroxyapatite | |
| BONE | Adriyan S. Milevª, GS Kamali Kannangara ª, Besim Ben-Nissan and Michael A. Wilson a College of Science, Technology and Environment, University of Western |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |